Periprocedural Myocardial Infraction: A Review Article

Irma Kamelia Pratiwi (Dept. Jantung dan Pembuluh Darah, Fakultas Kedokteran Universitas Brawijaya)
Fandy Hazzy Alfatta (Dept. Jantung dan Pembuluh Darah, Fakultas Kedokteran Universitas Brawijaya)
Teguh Aryanugraha (Dept. Jantung dan Pembuluh Darah, Fakultas Kedokteran Universitas Brawijaya)
Muhamad Bayu Aji (Dept. Jantung dan Pembuluh Darah, Fakultas Kedokteran Universitas Brawijaya)
Putri Annisa Kamila (Dept. Jantung dan Pembuluh Darah, Fakultas Kedokteran Universitas Brawijaya)
Ratna Pancasari (Dept. Jantung dan Pembuluh Darah, Fakultas Kedokteran Universitas Brawijaya)
Ayu Asri Devi (Dept. Jantung dan Pembuluh Darah, Fakultas Kedokteran Universitas Brawijaya)
Krishna Ari Nugraha (Dept. Jantung dan Pembuluh Darah, Fakultas Kedokteran Universitas Brawijaya)
Mohammad Saifur Rohman (Dept. Jantung dan Pembuluh Darah, Fakultas Kedokteran Universitas Brawijaya)

Heart Science Journal
Vol 3, No 1 (2022): Assesment and Outcome of Coronary Artery Disease in the Reperfusion Era

Percutaneous coronary intervention can be associated with several complications such as periprocedural myocardial infarction (PPMI) that was defined as an elevation of CK-MB >3 times the upper limit of the normal range in at least two blood samples with a normal range of baseline value, prolonged ischemia as demonstrated by persistent chest pain (>20 min), or new pathological Q waves seen on the electrocardiogram.By epidemiology, periprocedural myocardial infarction was happen in about 6 – 7% patient underwent PCI and associated with adverse outcome. Therefore it is important to identify the possible factors to detect, prevent and manage this event.